Harsco Corporation

Harsco Rail Executes Agreement to Exit Deutsche Bahn Engineered-to-Order Contract and Receives Initial Payment from Sale of Project Assets to GBM

Harsco Environmental Secures 10-Year Contract Renewal with EZS

Harsco Environmental Recognized in Three Newsweek America's Greatest Workplaces Awards

Harsco Environmental Secures New 10-Year Contract With Lloyds Metals and Energy Limited

Harsco Environmental Expands Presence in Central Europe With Two New Contracts in Slovakia

Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June

Harsco Environmental Opens First SteelPhalt™ Plant Outside the UK

Harsco Environmental Secures Contract with İzmir Demir Çelik Sanayi A.Ş. (İDÇ)

Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD

Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™

BioLineRx Announces Clinical Trial Agreement with St. Jude Children's Research Hospital, Inc. to Evaluate Motixafortide for CD34+ Hematopoietic Stem Cell (HSC) Mobilization For Gene Therapy Applications in Sickle Cell Disease (SCD)

Panagora Asset Management Inc. Invests $3.12 Million in Enviri Co. (NYSE:NVRI)

Harsco changes name to Enviri, to trade on ticker ‘NVRI'

Are Business Services Stocks Lagging Crawford & Company (CRD.A) This Year?

Despite Fast-paced Momentum, Harsco (HSC) Is Still a Bargain Stock

Does Harsco (HSC) Have the Potential to Rally 25.78% as Wall Street Analysts Expect?

Harsco Corporation: Investing In A Greener Future

Harsco Corporation (HSC) Q1 2023 Earnings Call Transcript

Harsco (HSC) Reports Q1 Loss, Tops Revenue Estimates

Harsco Corporation Announces Timing of First Quarter 2023 Results and Conference Call